Ireland
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 66.36 B
|
Nov. 30, 2024 | USD 348.99 | -0.04% |
|
Ireland |
|
2 |
USD 34.95 B
|
Dec. 31, 2023 | USD 92.69 | 1.24% |
|
Ireland |
|
3 |
USD 33.00 B
|
Oct. 25, 2024 | USD 85.25 | 4.23% |
|
Ireland |
|
4 |
USD 25.06 B
|
March 31, 2024 | USD 61.59 | -0.70% |
|
Ireland |
|
5 |
USD 23.20 B
|
Dec. 31, 2023 | USD 340.14 | -0.22% |
|
Ireland |
|
6 |
USD 22.95 B
|
Sept. 30, 2024 | USD 80.21 | 1.15% |
|
Ireland |
|
7 |
USD 20.05 B
|
Dec. 31, 2023 | USD 61.47 | 1.42% |
|
Ireland |
|
8 |
USD 17.68 B
|
Dec. 31, 2023 | USD 382.71 | 1.52% |
|
Ireland |
|
9 |
USD 14.69 B
|
Sept. 30, 2024 | USD 17.44 | 1.99% |
|
Ireland |
|
10 |
USD 14.51 B
|
March 31, 2024 | USD 19.10 | 2.60% |
|
Ireland |
|
11 |
USD 13.75 B
|
Dec. 31, 2023 | USD 52.93 | 1.48% |
|
Ireland |
|
12 |
USD 13.38 B
|
Dec. 31, 2023 | USD 362.65 | 2.25% |
|
Ireland |
|
13 |
USD 11.79 B
|
Dec. 31, 2023 | USD 259.60 | 1.17% |
|
Ireland |
|
14 |
USD 8.93 B
|
Dec. 31, 2023 | USD 67.20 | 1.30% |
|
Ireland |
|
15 |
USD 8.85 B
|
Dec. 31, 2023 | USD 93.99 | 0.60% |
|
Ireland |
|
16 |
USD 8.25 B
|
Dec. 31, 2023 | USD 12.82 | 3.22% |
|
Ireland |
|
17 |
USD 8.12 B
|
Dec. 31, 2023 | USD 200.24 | -8.14% |
|
Ireland |
|
18 |
USD 7.57 B
|
Dec. 31, 2023 | USD 95.81 | 1.17% |
|
Ireland |
|
19 |
USD 7.26 B
|
Sept. 27, 2024 | USD 91.23 | 2.59% |
|
Ireland |
|
20 |
USD 7.10 B
|
March 31, 2024 | USD 42.18 | 0.76% |
|
Ireland |
|
21 |
USD 5.99 B
|
Dec. 31, 2023 | USD 14.10 | 1.95% |
|
Ireland |
|
22 |
USD 5.42 B
|
Sept. 30, 2024 | USD 207.57 | 0.10% |
|
Ireland |
|
23 |
USD 4.99 B
|
Dec. 31, 2023 | USD 5.75 | 1.52% |
|
Ireland |
|
24 |
USD 4.96 B
|
Dec. 31, 2023 | USD 9.35 | 1.50% |
|
Ireland |
|
25 |
USD 4.66 B
|
Dec. 31, 2023 | USD 23.51 | -3.41% |
|
Ireland |
|
26 |
USD 3.94 B
|
March 31, 2024 | USD 31.56 | 3.45% |
|
Ireland |
|
27 |
USD 3.83 B
|
Dec. 31, 2023 | USD 122.96 | -0.16% |
|
Ireland |
|
28 |
USD 3.65 B
|
Dec. 31, 2023 | USD 129.75 | 1.16% |
|
Ireland |
|
29 |
USD 3.34 B
|
Sept. 30, 2024 | USD 71.41 | 0.03% |
|
Ireland |
|
30 |
USD 2.95 B
|
Dec. 31, 2023 | USD 10.39 | 0.85% |
|
Ireland |
|
31 |
USD 2.82 B
|
Dec. 31, 2023 | USD 2.05 | 2.67% |
|
Ireland |
|
32 |
USD 2.42 B
|
Sept. 30, 2024 | USD 2.07 | -1.42% |
|
Ireland |
|
33 |
USD 2.21 B
|
July 31, 2024 | USD 2.75 | -0.51% |
|
Ireland |
|
34 |
USD 1.79 B
|
Feb. 29, 2024 | USD 1.71 | 0.81% |
|
Ireland |
|
35 |
USD 1.66 B
|
Dec. 31, 2023 | USD 28.50 | 0.53% |
|
Ireland |
|
36 |
USD 882.50 M
|
Dec. 31, 2023 | USD 5.70 | NA |
|
Ireland |
|
37 |
USD 737.30 M
|
Dec. 31, 2023 | USD 1.42 | 1.34% |
|
Ireland |
|
38 |
USD 735.99 M
|
Dec. 31, 2023 | USD 2.12 | -1.78% |
|
Ireland |
|
39 |
USD 671.01 M
|
Dec. 31, 2023 | USD 1.53 | -1.39% |
|
Ireland |
|
40 |
USD 670.75 M
|
Dec. 31, 2023 | USD 4.84 | 3.24% |
|
Ireland |
|
41 |
USD 631.35 M
|
Dec. 31, 2023 | USD 5.42 | 2.16% |
|
Ireland |
|
42 |
USD 458.48 M
|
Dec. 31, 2023 | USD 4.02 | 4.91% |
|
Ireland |
|
43 |
USD 387.40 M
|
Dec. 31, 2023 | USD 12.99 | -0.97% |
|
Ireland |
|
44 |
USD 173.21 M
|
Dec. 31, 2023 | USD 0.45 | 0.01% |
|
Ireland |
|
45 |
USD 136.80 M
|
Dec. 31, 2023 | USD 15.26 | 1.06% |
|
Ireland |
|
46 |
USD 134.92 M
|
Dec. 31, 2023 | USD 1.18 | 0.24% |
|
Ireland |
|
47 |
USD 102.94 M
|
Dec. 31, 2023 | USD 1.68 | 1.94% |
|
Ireland |
|
48 |
USD 102.41 M
|
Dec. 31, 2023 | USD 69.11 | -2.10% |
|
Ireland |
|
49 |
USD 91.37 M
|
Dec. 31, 2023 | USD 12.67 | -3.50% |
|
Ireland |
|
50 |
USD 79.46 M
|
Dec. 31, 2023 | USD 3.09 | 4.39% |
|
Ireland |
The company in Ireland with the highest Revenue is Accenture plc (NYSE: ACN) at USD 66.36 B.
The company in Ireland with the lowest Revenue is Iterum Therapeutics plc (NasdaqCM: ITRM) at USD 0.00.
The top 10 companies in Ireland by Revenue are Accenture plc, CRH plc, Medtronic plc, DCC plc, Eaton Corporation plc, Johnson Controls International plc, Aptiv PLC, Trane Technologies plc, Adient plc and Ryanair Holdings plc.
The bottom 10 companies in Ireland by Revenue are Iterum Therapeutics plc, Mural Oncology plc, Ovoca Bio plc, Petrel Resources Plc, GH Research PLC, Aminex PLC, kneat.com, inc., Avadel Pharmaceuticals plc, Navitas Semiconductor Corporation and Prothena Corporation plc.